Abstract
Endothelial cell protein C receptor (EPCR) has important functions in regulation of coagulation and inflammation. EPCR shedding from the cell surface is mediated by tumor necrosis factor-α converting enzyme (TACE). Rutin is one of the major flavonoids from the buckwheat plant Fagopyrum tataricum. In this study, we investigated the effects of rutin on phorbol-12-myristate 13-acetate (PMA), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and on cecal ligation and puncture (CLP)-mediated EPCR shedding. We used a CLP model because this model more closely resembles human sepsis. Data showed rutin was a potent inhibitor of PMA, TNF-α, IL-1β, and CLP-induced EPCR shedding by suppression of TACE expression. Treatment with rutin resulted in a decrease of PMA-stimulated phosphorylation of p38, extracellular regulated kinases 1/2, and c-Jun N-terminal kinase. These results suggest the potential application of rutin for treatment of PMA and CLP-mediated EPCR shedding.
Similar content being viewed by others
References
Fukudome, K., and C.T. Esmon. 1994. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. Journal of Biological Chemistry 269: 26486–26491.
Fukudome, K., S. Kurosawa, D.J. Stearns-Kurosawa, X. He, A.R. Rezaie, and C.T. Esmon. 1996. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. Journal of Biological Chemistry 271: 17491–17498.
Mosnier, L.O., B.V. Zlokovic, and J.H. Griffin. 2007. The cytoprotective protein C pathway. Blood 109: 3161–3172.
Kurosawa, S., D.J. Stearns-Kurosawa, C.W. Carson, A. D'Angelo, P. Della Valle, and C.T. Esmon. 1998. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91: 725–727.
Kurosawa, S., D.J. Stearns-Kurosawa, N. Hidari, and C.T. Esmon. 1997. Identification of functional endothelial protein C receptor in human plasma. Journal of Clinical Investigation 100: 411–418.
Liaw, P.C., P.F. Neuenschwander, M.D. Smirnov, and C.T. Esmon. 2000. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. Journal of Biological Chemistry 275: 5447–5452.
Stearns-Kurosawa, D.J., K. Swindle, A. D'Angelo, et al. 2002. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. Blood 99: 526–530.
Xu, J., D. Qu, N.L. Esmon, and C.T. Esmon. 2000. Metalloproteolytic release of endothelial cell protein C receptor. Journal of Biological Chemistry 275: 6038–6044.
Wang, L., J.A. Bastarache, N. Wickersham, X. Fang, M.A. Matthay, and L.B. Ware. 2007. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. American Journal of Respiratory Cell and Molecular Biology 36: 497–503.
Perez-Casal, M., C. Downey, K. Fukudome, G. Marx, and C.H. Toh. 2005. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood 105: 1515–1522.
Scaldaferri, F., M. Sans, S. Vetrano, et al. 2007. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. Journal of Clinical Investigation 117: 1951–1960.
Aggarwal, B.B., H. Ichikawa, P. Garodia, et al. 2006. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets 10: 87–118.
Ushida, Y., T. Matsui, M. Tanaka, et al. 2008. Endothelium-dependent vasorelaxation effect of rutin-free tartary buckwheat extract in isolated rat thoracic aorta. Journal of Nutrition and Biochemistry 19: 700–707.
Knekt, P., J. Kumpulainen, R. Jarvinen, et al. 2002. Flavonoid intake and risk of chronic diseases. American Journal of Clinical Nutrition 76: 560–568.
Guo, R., P. Wei, and W. Liu. 2007. Combined antioxidant effects of rutin and vitamin C in Triton X-100 micelles. Journal of Pharmaceutical and Biomedical Analysis 43: 1580–1586.
Korkmaz, A., and D. Kolankaya. 2010. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. Journal of Surgical Research 164: 309–315.
Milde, J., E.F. Elstner, and J. Grassmann. 2004. Synergistic inhibition of low-density lipoprotein oxidation by rutin, gamma-terpinene, and ascorbic acid. Phytomedicine 11: 105–113.
Lee, W., S.K. Ku, and J.S. Bae. 2012. Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo. Food and Chemical Toxicology 50: 3048–3055.
Borgel, D., C. Bornstain, P.H. Reitsma, et al. 2007. A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. American Journal of Respiratory and Critical Care Medicine 176: 878–885.
Bae, J.S., and A.R. Rezaie. 2011. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118: 3952–3959.
Kim, D.C., W. Lee, and J.S. Bae. 2011. Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflammation Research 60: 1161–1168.
Wang, H., H. Liao, M. Ochani, et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 10: 1216–1221.
Qu, D., Y. Wang, Y. Song, N.L. Esmon, and C.T. Esmon. 2006. The Ser219–Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. Journal of Thrombosis and Haemostasis 4: 229–235.
Qu, D., Y. Wang, N.L. Esmon, and C.T. Esmon. 2007. Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. Journal of Thrombosis and Haemostasis 5: 395–402.
Menschikowski, M., A. Hagelgans, G. Eisenhofer, and G. Siegert. 2009. Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Experimental Cell Research 315: 2673–2682.
Michie, H.R., K.R. Manogue, D.R. Spriggs, et al. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine 318: 1481–1486.
Kremer, J.P., D. Jarrar, U. Steckholzer, and W. Ertel. 1996. Interleukin-1, −6 and tumor necrosis factor-alpha release is down-regulated in whole blood from septic patients. Acta Haematologica 95: 268–273.
Yang, E.J., S.K. Ku, W. Lee, et al. 2013. Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo. Journal of Cellular Physiology 228: 975–982.
Buras, J.A., B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: setting the stage. Nature Reviews Drug Discovery 4: 854–865.
Yang, H., M. Ochani, J. Li, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proceedings of the National Academy of Sciences of the United States of America 101: 296–301.
Han, H., B. Du, X. Pan, et al. 2010. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Molecular Cancer Research 8: 1477–1488.
Leng, Y., T.L. Steiler, and J.R. Zierath. 2004. Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes 53: 1436–1444.
Sesin, C.A., X. Yin, C.T. Esmon, J.P. Buyon, and R.M. Clancy. 2005. Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney International 68: 110–120.
Ware, L.B., E. Camerer, K. Welty-Wolf, M.J. Schultz, and M.A. Matthay. 2006. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 291: L307–L311.
Esmon, C.T. 2005. The interactions between inflammation and coagulation. British Journal of Haematology 131: 417–430.
Bae, J.S., L. Yang, and A.R. Rezaie. 2007. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 104: 2867–2872.
van Hylckama Vlieg, A., R. Montes, F.R. Rosendaal, and J. Hermida. 2007. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis. Journal of Thrombosis and Haemostasis 5: 1449–1454.
Montes, R., V. Hurtado, A. Alonso, et al. 2005. Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women. Journal of Thrombosis and Haemostasis 3: 1454–1458.
Hurtado, V., R. Montes, J.C. Gris, et al. 2004. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood 104: 1369–1374.
Acknowledgments
This study was supported by the National Research Foundation of Korea (NRF) funded by the Korea government [MSIP] (Grant no. 2013–067053).
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ku, SK., Lee, IC., Han, MS. et al. Inhibitory Effects of Rutin on the Endothelial Protein C Receptor Shedding In Vitro and In Vivo . Inflammation 37, 1424–1431 (2014). https://doi.org/10.1007/s10753-014-9866-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9866-5